Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Clover Health Investments ( (CLOV) ).
On December 10, 2025, Clover Health Investments announced the performance outcomes of its subsidiary, Counterpart Health, Inc., and the adoption of its Counterpart Assistant technology by third-party customer clinicians. This development highlights the company’s strategic efforts to expand its technology solutions in the healthcare sector, particularly for Medicare-eligible populations, potentially impacting its market position and stakeholder interests.
The most recent analyst rating on (CLOV) stock is a Buy with a $3.70 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page.
Spark’s Take on CLOV Stock
According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.
Clover Health’s stock score is influenced by its ongoing financial challenges, despite positive developments in operational metrics and an encouraging earnings call. The financial performance remains a significant concern due to negative margins and revenue decline. Technical indicators signal potential weakness, while valuation remains unattractive due to losses. The company’s achievements in profitability and membership growth offer potential for future improvement.
To see Spark’s full report on CLOV stock, click here.
More about Clover Health Investments
Clover Health Investments, Corp. operates in the healthcare industry, focusing on providing technology-driven solutions to enhance healthcare services. The company offers the Clover Assistant technology, which is a software as a service platform designed to support payors and providers serving the Medicare eligible population.
Average Trading Volume: 8,833,065
Technical Sentiment Signal: Sell
Current Market Cap: $1.32B
For detailed information about CLOV stock, go to TipRanks’ Stock Analysis page.